An Open-label Study That Will Test a Second Treatment Session of RZL-012.

NCT05763160 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Raziel Therapeutics Ltd.